Improvement in Survival after Paraquat Ingestion with New Formulation
Author Information
Author(s): Martin Wilks, Fernando Ravindra, Ariyananda P. L, Eddleston Michael, Berry David J, Tomenson John A, Buckley Nicholas A, Jayamanne Shaluka, Gunnell David, Dawson Andrew
Primary Institution: Syngenta Crop Protection AG, Basel, Switzerland
Hypothesis
Does the new INTEON formulation of paraquat improve survival rates compared to the standard formulation?
Conclusion
The new INTEON formulation significantly reduces mortality and increases survival time for patients who ingest paraquat.
Supporting Evidence
- Survival rates increased from 27.1% with the standard formulation to 36.7% with INTEON.
- The median survival time improved from 2.3 days to 6.9 days with the new formulation.
- A higher percentage of patients vomited within 15 minutes after taking INTEON compared to the standard formulation.
Takeaway
A new version of a poison called paraquat helps people who accidentally take it to live longer and have a better chance of surviving.
Methodology
The study collected clinical data from 586 patients with paraquat ingestion across nine hospitals in Sri Lanka, comparing outcomes before and after the introduction of the new formulation.
Potential Biases
The study was funded by Syngenta, the manufacturer of both formulations, which may introduce bias.
Limitations
The study could not completely rule out other factors influencing survival rates, such as differences in treatment across hospitals.
Participant Demographics
Most patients ingested paraquat deliberately, with a mix of ages and genders.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI 2.0%–17.1%
Statistical Significance
p = 0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website